
Radiofrequency Ablation (RFA) is a minimally invasive medical procedure that uses high-frequency electrical currents to generate thermal energy (heat) to destroy small, targeted areas of tissue. In cardiology, it is primarily used to treat heart rhythm disorders (arrhythmias) by neutralizing the specific heart tissue responsible for abnormal electrical signals. RFA remains a cornerstone of electrophysiology, often providing a permanent cure for conditions that previously required lifelong medication.
Symptomatic Atrial Fibrillation (AFib) or Atrial Flutter that does not respond to medication.
Supraventricular Tachycardia (SVT) or Wolff-Parkinson-White (WPW) syndrome.
Frequent premature ventricular contractions (PVCs) that weaken the heart muscle.
Palpitations, dizziness, or fainting caused by documented electrical "short circuits" in the heart.
Patients who wish to avoid the long-term side effects or costs of anti-arrhythmic drugs.
Catheter Ablation: The standard approach using flexible tubes guided through the veins to the heart.
Cryoablation (Alternative): Using extreme cold instead of heat to freeze faulty heart tissue.
3D Electroanatomical Mapping: Creating a high-definition digital map of the heart's electrical activity to pinpoint the arrhythmia source.
Point-by-Point Ablation: Precisely cauterizing tiny spots (about 1/5th of an inch) to create a protective scar.
Pulmonary Vein Isolation (PVI): A specialized RFA technique used specifically to treat Atrial Fibrillation.
Access: Specialized electrode catheters are guided through the veins, usually starting from a small puncture in the groin.
EP Study: Doctors "map" the heart’s electrical system to identify exactly where the irregular rhythm begins.
Energy Delivery: The tip of the ablation catheter delivers radiofrequency energy to "cauterize" the target tissue, creating a small scar.
Signal Blocking: The resulting scar tissue acts as a permanent barrier that blocks faulty electrical signals from spreading.
Verification: The clinical team attempts to "re-trigger" the arrhythmia to ensure the treatment was successful before removing the catheters.
Fasting for 6–8 hours before the procedure, as it is usually performed under sedation or general anesthesia.
Blood tests to check kidney function and blood clotting levels.
Adjusting current heart medications or blood thinners as directed by your Electrophysiologist (EP).
Discussing any history of allergies to contrast dye or local anesthetics.
Arranging for a hospital stay (usually one night) and a support person for the journey home.
Electrocardiogram (ECG): To record the baseline heart rhythm and identify the type of arrhythmia.
Holter Monitor: A portable device worn for 24–48 hours to capture infrequent rhythm disturbances.
Echocardiogram: To evaluate the heart's structure and ensure there are no blood clots in the chambers.
Transesophageal Echo (TEE): A more detailed ultrasound performed just before ablation to confirm the heart is clear of clots.
Electrophysiology (EP) Study: The definitive diagnostic test performed at the start of the ablation procedure.
Short recovery time; most patients stay one night for observation and return home the next day.
Resume light daily activities within 24 to 48 hours, avoiding strenuous exercise for 1–2 weeks.
Temporary "Post-ablation syndrome" (mild flu-like symptoms) may occur for a few days as the heart heals.
Continued heart monitoring for several months to ensure the rhythm remains stable.
Significant reduction or total elimination of heart palpitations and associated fatigue.
High success rates, ranging from 90% to 98% for common arrhythmias like SVT.
Offers a potential permanent cure, often allowing patients to stop taking heart rhythm medications.
Minimally invasive with a much faster recovery than traditional open-heart surgery.
Protects the heart from long-term damage and failure caused by chronic high heart rates.
Improves overall quality of life by removing the anxiety and physical limitations of arrhythmias.